Latest Content

Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma

November 14th 2024, 4:00pm

By Spencer Feldman

Video

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.

A Phase 3 Trial of Amezalpat in Advanced Liver Cancer Receives Study May Proceed Letter

November 14th 2024, 2:00pm

By Ryan Scott

Article

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA.

Jemperli-Chemo Regimen Shows Survival Promise in Advanced NSCLC

November 13th 2024, 10:00pm

By Ariana Pelosci

Article

In patients with advanced NSCLC, treatment with Jemperli plus chemotherapy showed promising effectiveness compared with Keytruda plus chemotherapy.

Lymphedema Myths and Misconceptions, From Exercise to Blood Draws

November 13th 2024, 8:00pm

By Alex Biese

Article

An expert explains how attitudes towards lymphedema risk have evolved over the years.

My Traumas Associated With Follicular Lymphoma

November 13th 2024, 6:00pm

By Karen Cohn

Article

I’ve heard that trauma doesn’t make people stronger, and I’ve found that after cancer, I’m not the same person that I was before.

‘Full House’ Star Dave Coulier Has Non-Hodgkin Lymphoma

November 13th 2024, 4:03pm

By Alex Biese

Article

The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.

TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in Melanoma

November 13th 2024, 2:00pm

By Darlene Dobkowski, MA

Video

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.

THIO Plus Libtayo May Be Effective in NSCLC

November 12th 2024, 10:00pm

By Kyle Doherty

Article

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant non-small cell lung cancer.

QOL a Crucial Consideration During R/R Myeloma Treatment Decision-Making

November 12th 2024, 8:00pm

By Ashley Chan

Article

Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.

My Mammogram Prayers After Breast Cancer

November 12th 2024, 6:00pm

By Laura Yeager

Article

Having a collection of prayers before, during and after a mammogram has helped ease my mind tremendously after having breast cancer.

3 Cycles of Chemo as Beneficial as 6 in Pediatric Retinoblastoma

November 12th 2024, 4:12pm

By Alex Biese

Article

Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.

Managing Trodelvy’s Side Effects Through Dose Adjustment

November 12th 2024, 2:00pm

By Spencer Feldman

Article

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose adjustments.

Tracking Side Effects May Help Patients With Breast Cancer Communicate Concerns

November 11th 2024, 10:00pm

By Darlene Dobkowski, MA

Video

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best approaches to tracking side effects for patients with breast cancer.

Understanding Common Side Effects of Breast Cancer Treatment

November 11th 2024, 10:00pm

By Darlene Dobkowski, MA

Video

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side effects of breast cancer treatment.

Mitigating Side Effects During Breast Cancer Treatment

November 11th 2024, 10:00pm

By Darlene Dobkowski, MA

Video

CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.